Showing results (61-70 of 214) with videos related to

Sort By:
Pageof 22
AIDS (London, England)|May 16, 2007
Progression of carotid artery intima-media thickening in HIV-infected and uninfected adultsJudith S Currier, Michelle A Kendall, W Keith Henry, et al.
AIDS (London, England)|July 10, 2010
Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individualsPablo Tebas, Ian Frank, Mark Lewis, et al.
Human Vaccines & Immunotherapeutics|September 21, 2013
Tolerability of intramuscular and intradermal delivery by CELLECTRA(®) adaptive constant current electroporation device in healthy volunteersMalissa C Diehl, Jessica C Lee, Stephen E Daniels, et al.
Annals of Internal Medicine|January 2, 2013
Improved immunogenicity with high-dose seasonal influenza vaccine in HIV-infected persons: a single-center, parallel, randomized trialNoah McKittrick, Ian Frank, Jeffrey M Jacobson, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 13, 2004
Niacin in HIV-infected individuals with hyperlipidemia receiving potent antiretroviral therapyMarisa T Gerber, Kristin E Mondy, Kevin E Yarasheski, et al.
The Lancet. Infectious Diseases|June 9, 2014
Simplification to coformulated elvitegravir, cobicistat, emtricitabine, and tenofovir versus continuation of ritonavir-boosted protease inhibitor with emtricitabine and tenofovir in adults with virologically suppressed HIV (STRATEGY-PI): 48 week results of a randomised, open-label, phase 3b, non-inferiority trialJose R Arribas, Gilles Pialoux, Joseph Gathe, et al.
Plos One|August 30, 2014
The RADAR study: week 48 safety and efficacy of RAltegravir combined with boosted DARunavir compared to tenofovir/emtricitabine combined with boosted darunavir in antiretroviral-naive patients. Impact on bone healthRoger J Bedimo, Henning Drechsler, Mamta Jain, et al.
AIDS Research and Human Retroviruses|October 27, 2015
Effects of Pegylated Interferon/Ribavirin on Bone Turnover Markers in HIV/Hepatitis C Virus-Coinfected PatientsRoger Bedimo, Minhee Kang, Pablo Tebas, et al.
AIDS (London, England)|December 24, 2010
Vitamin D deficiency is associated with type 2 diabetes mellitus in HIV infectionZsofia Szep, Giovanni Guaraldi, Samir S Shah, et al.
Plos Medicine|January 19, 2006
Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapyAndrea S Foulkes, David A Wohl, Ian Frank, et al.
Pageof 22